Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study.
Axitinib is a second-generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3). Through this mechanism of action, axitinib blocks angiogenesis, tumor growth and metastases and therefor it shows significant promi...
Saved in:
| Main Authors: | Randa Mohammed Zaki, Basmah Nasser Aldosari, Layla A Alkharashi, Alyaa Alsalhi, Obaid Afzal, Bodoor Ghanem Alanazi, Maha Alsunbul, Rawan Bafail, Fatma I Abo El-Ela, Hanan O Farouk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0325055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity.
by: Randa Mohammed Zaki, et al.
Published: (2025-01-01) -
Impact of Formulation Variables on Meloxicam spanlastics Preparation
by: Lubna Sabri, et al.
Published: (2024-12-01) -
The Anticancer Effect of RAD51-IN-1 in MDAH-2774 (CVCL_0420) Cells
by: Deniz ÖZDEMİR, et al.
Published: (2025-04-01) -
Spanlastics Nanovesicles: An Emerging and Innovative Approach for Drug Delivery
by: Shaimaa N. Abd Alhammid, et al.
Published: (2023-09-01) -
Diskurzivne značilnosti sms-ov
by: Urška Jarnovič
Published: (2007-02-01)